Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma
about
Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma
description
scientific article published on 21 August 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2018
@uk
name
Akt and mTORC1 signaling as pr ...... dy nimotuzumab in glioblastoma
@en
Akt and mTORC1 signaling as pr ...... dy nimotuzumab in glioblastoma
@nl
type
label
Akt and mTORC1 signaling as pr ...... dy nimotuzumab in glioblastoma
@en
Akt and mTORC1 signaling as pr ...... dy nimotuzumab in glioblastoma
@nl
prefLabel
Akt and mTORC1 signaling as pr ...... dy nimotuzumab in glioblastoma
@en
Akt and mTORC1 signaling as pr ...... dy nimotuzumab in glioblastoma
@nl
P2093
P2860
P50
P1476
Akt and mTORC1 signaling as pr ...... dy nimotuzumab in glioblastoma
@en
P2093
Dirk Reuter
Hans Urban
Joachim P Steinbach
Manfred Westphal
Michel Mittelbronn
Pia S Zeiner
Torsten Pietsch
P2860
P2888
P356
10.1186/S40478-018-0583-4
P407
P577
2018-08-21T00:00:00Z
P6179
1106281045